(Q46626856)

23 December 2017

title

Low rate of emergence of clarithromycin-resistant Helicobacter pylori with amoxycillin co-therapy (English)

1 reference

23 December 2017

1 reference

1 reference

Laine L

1

1 reference

23 December 2017

Suchower L

2

1 reference

23 December 2017

Frantz J

3

1 reference

23 December 2017

Connors A

4

1 reference

23 December 2017

Neil G

5

1 reference

23 December 2017

language of work or name

English

0 references

publication date

1 September 1998

1 reference

23 December 2017

Alimentary Pharmacology & Therapeutics

published in

1 reference

23 December 2017

volume

12

1 reference

23 December 2017

issue

9

1 reference

23 December 2017

page(s)

887-892

1 reference

23 December 2017

Resistance of Helicobacter pylori to antibiotics

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1998.00378.X

Double-blind, multicenter, placebo-controlled evaluation of clarithromycin and omeprazole for Helicobacter pylori-associated duodenal ulcer

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1998.00378.X

Failed treatment of Helicobacter pylori infection associated with resistance to clarithromycin

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1998.00378.X

Ranitidine bismuth citrate plus clarithromycin is effective for healing duodenal ulcers, eradicating H. pylori and reducing ulcer recurrence. RBC H. pylori Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1998.00378.X

10.1046/J.1365-2036.1998.00378.X

21 January 2018

Identifiers

DOI

1 reference

23 December 2017

PubMed ID

9768532

1 reference

23 December 2017